Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2007 / Cilt: 33 - Sayı: 2

The evaluation of biochemical risk factors for recurrent urinary stone disease

Tekrarlayan taş hastalığında biyokimyasal risk etkenlerinin değerlendirilmesi

Pages
205–212
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This approach may eliminate the need for detailed, time-consuming, expensive tests.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: It is established that any urinary stone that receives no medical treatment, recurs in 50% of the patients and especially affects the young generation, causing a considerable morbidity and loss of working hours.
📊
Key Findings & Data:Materials and Methods: Our study groups consist of 118 patients, 76 males and 42 females, who were referred to our department between January 2000 to June 2003 for their recurrent and/or bilateral urinary stone disease and 53 others with no urinary stone disease history.
💡
Conclusion & Impact:This approach may eliminate the need for detailed, time-consuming, expensive tests.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Tekrarlama · Biyokimya · Üriner taş

Abstract

Introduction: It is established that any urinary stone that receives no medical treatment, recurs in 50% of the patients and especially affects the young generation, causing a considerable morbidity and loss of working hours. We aimed to investigate the differences between biochemical profiles of the normal and stoneproducing populations, in order to determine the risk groups that require a metabolic evaluation and the extent of that evaluation. Materials and Methods: Our study groups consist of 118 patients, 76 males and 42 females, who were referred to our department between January 2000 to June 2003 for their recurrent and/or bilateral urinary stone disease and 53 others with no urinary stone disease history. Each subject was evaluated for serum biochemistry and stone composition and calcium, oxalate, citrate, uric acid, sodium, potassium, magnesium, ascorbic acid, protein levels, and pH values in 24-hour collected urine. Results: The most frequent metabolic abnormality in these stone formers was hypocitraturia and even the controls were found to have severe hypocitraturia (<320 mg/day). These patients had higher urinary levels of calcium, uric acid, oxalate, sodium and ascorbic acid, when compared to the controls. Furthermore, their fasting glycemia, blood cholesterol and triglyceride levels were higher. According to the stone analysis, calcium oxalate stones were the most frequent, and magnesium ammonium phosphate stones constituted 24% of all stones. Conclusion: Our findings suggest that males with urinary stone disease who have high fasting glycemia, blood cholesterol, triglyceride and creatinine values have a higher tendency for recurrence of stones and they should be evaluated in terms of hypocitraturia, hypercalciuria, hyperoxaluria, hyperuricosuria. This approach may eliminate the need for detailed, time-consuming, expensive tests.

Özet

Özellikle genç yaştaki hastalarda ciddi morbidite ve iş gücü kaybına neden olan bir üriner sistem taşının herhangi bir tıbbi tedavi almaması durumunda %50 oranında tekrarladığı bilinmektedir. Biz çalışmamızda, tekrarlayan veya iki taraflı üriner sistem taş hastalığı olanlar ile sağlam olguların biyokimyasal profillerini değerlendirip, hangi hastalar için metabolik araştırma gereklidir sorusuna cevap bulabilmeyi amaçladık. Bu nedenle 76 erkek, 42 kadın toplam 118 taşlı hasta ile 53 sağlam olgu serum biyokimyası ve 24 saatlik idrardaki değerleri açısından karşılaştırıldı. Taş hastalığının, özellikle genç yaştaki erkeklerde daha sık görüldüğü, en sık görülen metabolik anormalliğin hipositratüri olduğu ve bu hastaların sağlam olgulara göre 24 saatlik idrarlarında daha yüksek oranda ürik asit, kalsiyum, oksalat, sodyum ve askorbik asit bulunduğu tespit edildi. Serum biyokimyaları karşılaştırıldığında, taş hastalarının açlık glisemisi, kolesterol ve trigliserid değerlerinin sağlam olgulara göre daha fazla olduğu görüldü. Sonuç olarak, taş hastalığına sahip, erkek olgulardan rutin biyokimyasal analizlerinde yüksek açlık serum glisemi, kolesterol, trigliserid ve kreatinin değerlerine sahip ve idrarlarında proteinürisi olanlar, hastalığın tekrarlaması açısından riskli olarak değerlendirilmeli ve 24 saatlik idrarda en sık görülen, basit ve ucuz olarak tespit edilebilen hipositratüri, hiperkalsiüri, hiperoksalüri ve hiperürikozüri açısından araştırılmalıdır. Ancak bu şekilde ayrıntılı, zaman alıcı ve pahalı araştırma ve tetkiklerin uygulanmasına gerek olmayabilecektir.

🔖

Cite This Article

ADAYENER, C., AKYOL, İ., ŞEN, B., ATEŞ, F., BAYKAL, K., İŞERİ, C. (2007). The evaluation of biochemical risk factors for recurrent urinary stone disease. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 33 - Sayı: 2, 205–212. https://ajindex.com/articles/328340

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Pearle MS, Lotan Y: Urinary Lithiasis: Etiology, Epidemiology and Pathogenesis. Campbell’s Urology, (eds) Wein, Kavoussi, Novick, Partin, Peters., Ninth Edition Vol 2 Chapter 42, Philadelphia Pennsylvania, Saunders Company, 1363-1392, 2007
  2. Menon M, Parulkar BG, Drach GW: Urinary Lithiasis: Etiology, Diagnosis and Medical Management. Campbell’s Urology, (eds) Walsh, P.C., Retik, A.B., Vaughan Jr, E.D., Wein, A.J., Seventh Edition Vol III; Philadelphia, Pennsylvania, W.B. Saunders Company, 2661-2733, 1998
  3. Uribarri J, Men S, Carrol JH: The First Kidney Stone. Ann Intern Med.; 111: 1006-1009, 1989
  4. Chalmers AH, Lark J: Urinary Ascorbate Measurement by Rate Analysis in a Centrifugal Analyzer. Clin Chemistry; 31: 353-354, 1985
  5. Holt C, Cowley DM, Chalmers AH: Rapid Estimation of Urinary Citrate by Use of a Centrifugal Analyser. Clin Chemistry; 31: 779-780, 1985
  6. Kohri K, Ishikawa Y, Katoh Y, Kataoka K, Iguchi M, Yachiku S, Kurita: Epidemiology of Urolithiasis in the Elderly. Int Urol Nephrol; 23: 413-421, 1991
  7. Stoller ML, Bolton DM: Urinary Stone Disease. Smith’s General Urology, (eds) Tanagho, E.A., Mc Aninch, J.W., Fourteenth Edition, Connecticut, Appleton and Lange Company, 276-304, 1995
  8. Lee YH, Huang WC, Tsai JY, Huang JK: The Efficacy of Potassium Citrate Based Medical Prophylaxis for Preventing Upper Urinary Tract Calculi: A Midterm Followup Study. J Urol; 161: 1453-1457, 1999
  9. Donald LG, Stoller ML, Bruce JE, Leslie SW: Geriatric Urolithiasis. J Urol; 158: 2221-2224, 1997
  10. Pak CYC, Resnick MI, Preminger GM: Ethnic and Geographic Diversity of Stone Disease. Urology; 50: 504-507, 1997
  11. Osther PJ: Hyperoxaluria in Idiopathic Calcium Nephrolithiasis. Scand J Urol Nephrol. 33: 368-371, 1999
  12. Tekin A, Tekgül S, Atsu N, Şahin A, Özen H, Bakkaloğlu M: A Study of the Etiology of Idiopathic Calcium Urolithiasis in Children: Hypocitraturia is the Most Important Risk Factor. J Urol; 164: 162-165, 2000
  13. Tefekli A, Esen T, Ziylan O, Erol B, Armağan A, Ander H, Akıncı M: Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: Is there any difference? Urol Int 70: 273-7, 2003
  14. Miyake O, Yoshimura K, Tsujihata M, Yoshioka T, Koide T, Takahara S, Okuyama A: Possible Causes for the Low Prevalance of Pediatric Urolithiasis. Urology; 53: 1229-1234, 1999
  15. Urivetzky M, Kessaris D, Smith AD: Ascorbic Acid Overdosing: A Risk Factor for Calcium Oxalate Nephrolithiasis. J Urol 147:1215-1219, 1992. 1